Stock NATCOPHARM NATCO PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News NATCO Pharma Limited

Equities

NATCOPHARM

INE987B01026

Market Closed - NSE India S.E.
Other stock markets
 03:14:50 2024-05-18 am EDT 		5-day change 1st Jan Change
999.4 INR +0.43% Intraday chart for NATCO Pharma Limited +2.56% +23.18%
May. 08 AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents MT
May. 08 AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents
MT
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents
MT
AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement
MT
Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit
MT
NATCO Pharma Limited Announces Board Appointments
CI
INDIA STOCKS-Indian shares erase early gains, weighed down by IT stocks
RE
NATCO Pharma Limited Revises Earnings Guidance for the Fiscal Year 2024
CI
Transcript : NATCO Pharma Limited, Q3 2024 Earnings Call, Feb 15, 2024
Corporate Action-Board Approves Third Interim Dividend for the Financial Year 2023-24, Payable on 4 March 2024
CI
NATCO Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Cellogen Therapeutics announced that it has received $2 million in funding from NATCO Pharma Limited
CI
Floods Disrupt Operations of Natco Pharma's Plant in Tamil Nadu, India
MT
Transcript : NATCO Pharma Limited, Q2 2024 Earnings Call, Nov 15, 2023
Natco Pharma's Consolidated Profit Soars in Fiscal Q2, Declares Second Interim Dividend
MT
NATCO Pharma Limited Declares Second Interim Dividend for the Financial Year 2023-24, Payable on 1 December, 2023
CI
NATCO Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
US FDA Clears Natco Pharma's Pharmacovigilance Department in Hyderabad, India
MT
Transcript : NATCO Pharma Limited - Shareholder/Analyst Call
Redcliffe Hygiene Private Limited announced that it has received INR 248 million in funding from Rainmatter, Alkemi Growth Capital LLP, NATCO Pharma Limited
CI
Indian Equities End Higher for Sixth Straight Day, Buoyed by Banking, Public Sector Enterprises
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NATCOPHARM Stock
  4. News NATCO Pharma Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW